Related Experiment Video
Updated: Sep 17, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
NT-proBNP and BNP Testing in Pulmonary Arterial Hypertension: Point-of-Care and Remote Monitoring
Charlotte Durrington1,2, Christian Battersby1, Laura Holt1
1Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
Point-of-care N-terminal prohormone of brain natriuretic peptide (NT-proBNP) tests are reliable for pulmonary arterial hypertension (PAH) patients. NT-proBNP is also stable in mailed samples, supporting remote monitoring for PAH.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Biomarker Analysis
Background:
- Brain natriuretic peptide (BNP) and N-terminal prohormone of BNP (NT-proBNP) are key biomarkers for pulmonary arterial hypertension (PAH).
- Timely biomarker results are crucial for clinical assessment but often delayed.
- Investigating the reliability of point-of-care tests (POCT) and mailed samples for NT-proBNP is essential for efficient PAH management.
Purpose of the Study:
- To assess the reliability of NT-proBNP and BNP point-of-care tests (POCT) in PAH patients.
- To determine the stability of NT-proBNP in blood samples sent via mail for remote monitoring.
- To compare the diagnostic accuracy of NT-proBNP and BNP in risk stratification for PAH.
Main Methods:
- Prospective recruitment of Group 1 PAH patients.
- Comparison of laboratory and POCT NT-proBNP/BNP measurements.
- Analysis of NT-proBNP stability in postal samples and impact of exercise.
- Intraclass correlation coefficient (ICC) and Passing-Bablok regression for agreement assessment.
Main Results:
- NT-proBNP POCT and laboratory results showed excellent agreement (ICC=0.97).
- BNP POCT and laboratory results demonstrated non-equivalence.
- NT-proBNP showed good agreement in postal samples, unaffected by exercise.
- NT-proBNP risk stratification was more sensitive than BNP.
Conclusions:
- POCT NT-proBNP is a dependable and accessible alternative for clinical PAH assessment.
- NT-proBNP analysis from mailed samples shows promise for remote patient monitoring.
- NT-proBNP is a more effective biomarker for PAH risk stratification than BNP.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Pneumonia III: Complications and Assessment
Pre-Procedural Guidelines for Assessing Blood Pressure

